Shareholders meeting

September 04, 2026 BSE Limited National Stock Exchange of India Ltd. Corporate Relationship Department Exchange Plaza, P.J. Towers, Bandra-Kurla Complex, Dalal Street, Fort, Bandra (East) Mumbai - 400 001 Mumbai - 400 051 Scrip Code: 506109 Symbol: GENESYS Dear Sir/Madam, Sub: Submission of Notice of 44th Annual General Meeting (AGM) of the Company under SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Notice of 44th Annual General Meeting of the Company to be held on Wednesday, September 30, 2026 at 3:30 p.m. (IST) through Video Conferencing (“VC”) / Other Audio Visual Means (“OAVM”). The Notice has been sent through electronic mode to the Members, who have registered their e- mail addresses with the Company/Registrar & Transfer Agent (“RTA”)/Depository Participants(s)(“DP”). Further, in accordance with Regulation 36(1)(b) of the Listing Regulations, the Company has sent a letter to Shareholders whose e-mail addresses are not registered with Company/RTA/DPs providing the web-link Annual Report 2025-26, exact path and QR code, where complete details of the Annual Report are available to all the Members of the Company. Date and Time of Commencement of remote Wednesday, September 23, 2026 at 9.00 a.m e-voting (IST). Date and Time of Conclusion of remote e- Tuesday, September 29, 2026 at 5.00 p.m voting (IST). Cut-off date Friday, September 18, 2026 The above is also uploaded on the website of the Company www.igenesys.com. You are requested to take the same on record. Thanking You, Yours faithfully, For Genesys International Corporation Limited Kushal Jain Company Secretary & Compliance Officer Regd. Office: 73-A, SDF-III, SEEPZ, Andheri (E), Mumbai-400 096, India Tel.: +91-22-2829 0303; +91-22-4488 4488; Fax: +91-22-2829 0603 Website: www.igenesys.com; E-mail:investors@igenesys.com CIN: L65990MH1983PLC029197 NOTICE Notice is hereby given that the 44th (Forty Fourth) Annual M/s. M S K A & Associates, LLP, Chartered Accountants General Meeting (“AGM”) of Genesys International whose term shall expire at the conclusion of the ensuing Corporation Limited will be held on Wednesday, 44th Annual General meeting, to hold the office for the September 30, 2026 at 3:30 p.m. (IST) through video term of five (5) consecutive years from the conclusion conferencing (“VC”) / other audio-visual means of 44th Annual General Meeting (“AGM”) until the (“OAVM”) to transact the following business. The venue conclusion of 49th AGM at such remuneration as set out of the meeting shall be deemed to be the Registered in the explanatory statement annexed to this Notice. office of the Company. RESOLVED FURTHER THAT the Board of Directors ORDINARY BUSINESS: of the Company be and are hereby authorised to vary, alter, enhance or widen the remuneration payable to 1. To consider and adopt (a) the audited financial the Statutory Auditors, for the said tenure, from time statement of the Company for the financial year to time, pursuant to the recommendation of the Audit ended March 31, 2026 and the reports of the Board Committee, in consultation with the Statutory Auditors. of Directors and Auditors thereon; and (b) the audited consolidated financial statement of the RESOLVED FURTHER THAT any Director or Company Company for the financial year ended March 31, Secretary of the Company be and is hereby authorized 2026 and the report of Auditors thereon and in this to file necessary E-Forms, returns with the Registrar of regard, to consider and if thought fit, to pass the Companies and/or any other statutory authority and to following resolutions as Ordinary Resolutions: do all such acts, deeds and things as may be considered necessary to give effect the aforesaid resolution.” a) “RESOLVED THAT the audited standalone financial statement of the Company for the financial year ended SPECIAL BUSINESS: March 31, 2026 and the reports of the Board of Directors 4. Approval of Genesys International Corporation and Auditors thereon, as circulated to the members, be Limited – Employee Stock Option Plan (Genesys and are hereby considered and adopted.” ESOP Scheme 2026) b) “RESOLVED THAT the audited consolidated financial To consider and, if thought fit, to pass with or without statement of the Company for the financial year ended modification(s), the following resolution as Special March 31, 2026 and the report of Auditors thereon, Resolution: as circulated to the members, be and are hereby considered and adopted.” “RESOLVED THAT pursuant to the provisions of Section 62(1)(b) and other applicable provisions, if any, 2. To appoint Dr. Yogita Shukla (DIN:09286545), who of the Companies Act, 2013 (the “Act”) read with the retires by rotation, as a Director and in this regard, Companies (Share Capital and Debentures) Rules, to consider and if thought fit, to pass the following 2014 (“the Rules”) made thereunder (including any resolution as an Ordinary Resolution: amendment, modification, variation or re-enactment “RESOLVED THAT in accordance with the provisions thereof) , the Memorandum and Articles of Association of Section 152 and other applicable provisions of the of the Company, the circulars and notifications issued Companies Act, 2013, Dr. Yogita Shukla (DIN:09286545), by the Reserve Bank of India, Securities and Exchange who retires by rotation at this meeting, be and is hereby Board of India (Listing Obligations and Disclosure appointed as a Director of the Company.” Requirements) Regulations, 2015, Securities and Exchange Board of India (Share Based Employee 3. To appoint the Statutory Auditors of the Company Benefits and Sweat Equity ) Regulations, 2021, as and fix their remuneration amended from time to time, and applicable circulars To consider and, if thought fit, to pass with or without (collectively referred to as “SEBI (SBEB) Regulations”), modification(s), the following resolution as an Ordinary issued by the Securities and Exchange Board of India resolution: (“SEBI”) and subject to such other rules, regulations and guidelines that may be issued by appropriate authorities “RESOLVED THAT pursuant to the provisions of from time to time and subject to such other approval(s), Sections 139, 142 and all other applicable provisions, permission(s) and sanction(s) as may be necessary if any, of the Companies Act, 2013 read with the from time to time and such conditions and modifications Companies (Audit and Auditors) Rules, 2014 (including as may be prescribed or imposed while granting such any statutory modifications, amendments or re- approvals, permissions and sanctions which may enactments thereof for the time being in force, and be agreed to and accepted by the Board of Directors upon recommendation of the Audit Committee and the (hereinafter referred to as “the Board” which term shall Board of Directors, M/s G. K. Choksi & Co., Chartered be deemed to include Nomination & Remuneration Accountants (Firm Registration No. 125442W), be and Committee constituted by the Board of Directors under are hereby appointed as the Statutory Auditors of the applicable Regulation of SEBI (Share Based Employee Company in place of the retiring Statutory Auditors, Benefits and Sweat Equity) Regulations, 2021, the GENESYS INTERNATIONAL CORPORATION LIMITED approval and consent of the shareholders of the is hereby designated as Nomination & Remuneration Company be and is hereby accorded to the introduction Committee in pursuance of the SBEB Regulations for and implementation of Genesys ESOP Scheme 2026 the purpose of administration and superintendence of (“Scheme”), the salient features whereof are furnished the Scheme. in the explanatory statement to this Notice, and RESOLVED FURTHER THAT the Scheme shall be authorizing the Board of Directors to create, issue, offer implemented through a direct route, for extending the and allot equity shares and/or securities convertible benefits to the eligible Employees by way of fresh into equity shares (including any shares allotted to allotment and wil [Showing first 8,000 characters — download PDF for full document]